Astrazeneca Pharmaceuticals LP
Biopharmaceutical Company.
Based in DE
🤖
AI Overview
With $1.8M in lobbying spend across 27 quarterly filings, Astrazeneca Pharmaceuticals LP is a significant lobbying presence.
$1.8M
Total Lobbying Spend
27
Quarterly Filings
1
Lobbying Firms Used
1
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $200K |
| 2019 | $150K |
| 2020 | $120K |
| 2021 | $240K |
| 2022 | $240K |
| 2023 | $320K |
| 2024 | $240K |
| 2025 | $320K |
Lobbying Firms
W STRATEGIES, LLC
What They Lobby For
- H.R.1892: Bipartisan Budget Act of 2018 as it relates to a Part D donut hole provision and IPAB repeal. H.R.1625: Consolidated Appropriations Act, 2018.
- H.R.1834: Cancer Care Payment Reform Act of 2017. Education about innovative contracting and value based payments. Synchronization and Nonadherence Correction (SYNC) Act. H.R.849/H.J.Res 51: IPAB Repeal Act and Joint Resolution related to IPAB Repeal.
- Education about the 340(b) drug discount program including the CMS 340(b) CMP Rule. CDC Recommendations about flu treatments.
- H.R.1892: Bipartisan Budget Act of 2018 as it relates to a Part D donut hole provision.
- Education about innovative contracting and value based payments. Education about the 340(b) drug discount program including the CMS 340(b) CMP Rule.
- Education about innovative contracting and value based payments.
- H.R.6642: "to sunset the limit on maximum rebate amount for single source drugs".
- H.R.107: to sunset the limit on maximum rebate amount for single source drugs. Regulatory and legislative proposals in the Administrations Blueprint. H.R.2113: Prescription Drug STAR Act.
- H.R.107: to sunset the limit on maximum rebate amount for single source drugs. H.R.3: Lower Drug Costs Now Act of 2019. Regulatory and legislative proposals in the Administrations Blueprint. H.R.2113: Prescription Drug STAR Act / H.R.2296: FAIR Drug Pricing Act. FY 2020 Continuing Resolution.
- H.R.107: to sunset the limit on maximum rebate amount for single source drugs. H.R.3: Lower Drug Costs Now Act of 2019. H.R.19: Lower Costs, More Cures Act of 2019. Regulatory and legislative proposals in the Administrations Blueprint.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.